Search

Your search keyword '"Schadt, Eric"' showing total 147 results

Search Constraints

Start Over You searched for: Author "Schadt, Eric" Remove constraint Author: "Schadt, Eric" Publisher springer science and business media llc Remove constraint Publisher: springer science and business media llc
147 results on '"Schadt, Eric"'

Search Results

2. Circulating proteins to predict COVID-19 severity

3. A temporal classifier predicts histopathology state and parses acute-chronic phasing in inflammatory bowel disease patients

5. The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals

6. Large eQTL meta-analysis reveals differing patterns between cerebral cortical and cerebellar brain regions

7. Improving preeclampsia risk prediction by modeling pregnancy trajectories from routinely collected electronic medical record data

9. Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression

10. A mechanistic framework for cardiometabolic and coronary artery diseases

11. Impact of body mass index on the efficacy of aromatase inhibitors in patients with metastatic breast cancer

12. Population-based estimates of breast cancer risk for carriers of pathogenic variants identified by gene-panel testing

13. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes

14. Genetic variants associated with inherited cardiovascular disorders among 13,131 asymptomatic older adults of European descent

16. A composite biomarker of neutrophil-lymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers

17. An integrative multiomic network model links lipid metabolism to glucose regulation in coronary artery disease

18. Aberrant methylation underlies insulin gene expression in human insulinoma

19. An inflammatory cytokine signature predicts COVID-19 severity and survival

20. Multiscale causal networks identify VGF as a key regulator of Alzheimer’s disease

21. Genomic analyses implicate noncoding de novo variants in congenital heart disease

22. Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation

24. Intratumoral heterogeneity and clonal evolution in liver cancer

25. VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice

26. Sampling the host response to SARS-CoV-2 in hospitals under siege

27. Epigenomic characterization of Clostridioides difficile finds a conserved DNA methyltransferase that mediates sporulation and pathogenesis

28. Correction to: Integrative analysis of loss-of-function variants in clinical and genomic data reveals novel genes associated with cardiovascular traits

30. Discovering genetic interactions bridging pathways in genome-wide association studies

31. Integrative transcriptome imputation reveals tissue-specific and shared biological mechanisms mediating susceptibility to complex traits

32. Integrative analysis of loss-of-function variants in clinical and genomic data reveals novel genes associated with cardiovascular traits

34. High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis

37. Correction: Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden

38. Author Correction: Expression-based drug screening of neural progenitor cells from individuals with schizophrenia

39. Expression-based drug screening of neural progenitor cells from individuals with schizophrenia

40. Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer’s disease susceptibility

41. Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden

42. Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau

44. The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease

45. iPSC-derived familial Alzheimer’s PSEN2 N141I cholinergic neurons exhibit mutation-dependent molecular pathology corrected by insulin signaling

49. Integrated biology approach reveals molecular and pathological interactions among Alzheimer’s Aβ42, Tau, TREM2, and TYROBP in Drosophila models

Catalog

Books, media, physical & digital resources